February 7, 2020 / 2:08 PM / 5 months ago

BRIEF-Meridian Bioscience Reports First Quarter Fiscal 2020 Operating Results And Reaffirms 2020 Guidance

Feb 7 (Reuters) - Meridian Bioscience Inc:

* MERIDIAN BIOSCIENCE REPORTS FIRST QUARTER FISCAL 2020 OPERATING RESULTS AND REAFFIRMS 2020 GUIDANCE

* QTRLY NET REVENUES $47.4 MILLION VERSUS $51.5 MILLION

* MERIDIAN BIOSCIENCE - IN JAN, BEGAN SHIPPING MOLECULAR REAGENTS TO IVD MANUFACTURING CUSTOMERS IN CHINA TO HELP COMBAT CORONAVIRUS OUTBREAK

* “EXPECT IMPROVED PERFORMANCE IN REMAINING QUARTERS OF FISCAL YEAR”

* SHIPPING MOLECULAR REAGENTS TO IVD MANUFACTURING CUSTOMERS IN CHINA NOT INCLUDED IN OUR Q1 RESULTS

* MERIDIAN BIOSCIENCE - LIFE SCIENCE SEGMENT REVENUES FOR QUARTER REFLECTED LOWER ORDERING PATTERNS WITH TOP IVD MANUFACTURING CUSTOMERS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below